NEW Zealand pharmaceutical firm AFT Pharmaceuticals has extended its existing partnership agreements with the addition of a French pharmaceutical company to out-license the product line of its patented paracetamol/ibuprofen painkiller Maxigesic to France, Monaco, Andorra and French dependencies.
The name of the new French partner cannot be disclosed at this stage due to the country's labour laws and the "significant commercial value of the contract".
The announcement follows confirmation of EU approval of Maxigesic in nine additional countries including France (PD yesterday), with AFT md Hartley Atkinson saying "this is basically going to fast-track Maxigesic tablet sales in France".
The above article was sent to subscribers in Pharmacy Daily's issue from 23 May 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 May 17